Triple
T22693767
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | inotersen |
E561115
|
entity |
| Predicate | instanceOf |
P0
|
FINISHED |
| Object | antisense oligonucleotide drug |
C7485
|
CONCEPT FINISHED |
How this triple was built (1 step)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
CD
Concept disambiguation
gpt-5-mini-2025-08-07
Target class: antisense oligonucleotide drug Context triple: [inotersen, instanceOf, antisense oligonucleotide drug]
-
A.
antisense oligonucleotide
chosen
An antisense oligonucleotide is a short, synthetic strand of nucleic acid designed to bind specifically to a target RNA sequence and modulate its function, typically to alter gene expression for therapeutic purposes.
-
B.
small interfering RNA therapeutic
A small interfering RNA therapeutic is a short, double-stranded RNA molecule designed to selectively silence specific gene expression by promoting the degradation of complementary messenger RNA, thereby modulating disease-related pathways.
-
C.
RNA interference-based therapy
RNA interference-based therapy is a treatment approach that uses small RNA molecules to selectively silence disease-related genes by degrading their corresponding messenger RNA.
-
D.
RNA interference therapeutic
An RNA interference therapeutic is a drug that uses small RNA molecules to selectively silence specific gene expression by degrading target mRNA, thereby modulating disease-related biological pathways.
-
E.
NS5A inhibitor
An NS5A inhibitor is an antiviral drug that targets the nonstructural protein 5A of hepatitis C virus, disrupting viral RNA replication and assembly to prevent viral proliferation.
- F. None of above.
Provenance (1 batch)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e2454d71b48190a1f80af9f82b6fcf |
completed | April 17, 2026, 2:35 p.m. |
Created at: April 17, 2026, 3:13 p.m.